At a glance
- Originator Gene PreDiT
- Developer Blueclinical; Gene PreDiT
- Class Amines; Antihypertensives; Carboxylic acids; Indoles; Obesity therapies; Small molecules
- Mechanism of Action ACE inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Obesity
Most Recent Events
- 22 Oct 2020 No development reported - Phase-II for Obesity (In the elderly, In adults) in Portugal (PO) (Gene PreDiT website, October 2020)
- 24 May 2017 Chemical structure information added
- 28 Apr 2017 Gene PreDiT and Blueclinical terminate a phase II trial in Obesity (In adults, In the elderly) in Portugal (EudraCT2015-004275-70)